Nilotinib Monohydrochloride Monohydrate is used to treat Philadelphia chromosome positive chronic myelogenous leukaemia. It is sold under the brand name Tasigna. It is not safe for use during pregnancy. Reference standards of Nilotinib Monohydrochloride Monohydrate API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
Nilotinib Monohydrochloride Monohydrate
Catalogue No.:PA 14 85000
CAS :
Molecular Formula : C28H25ClF3N7O2
Molecular Weight : 583.99
4-Methyl-3-[[4-(pyridin-3-yl)pyrimidin-2-yl]amino]benzoic Acid
Catalogue No.:PA 14 85040
Molecular Formula : C17H14N4O2
Molecular Weight : 306.33
N-(3-(4-Ethyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl)-4-methyl-3-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)benzamide
Catalogue No.:PA 14 85060
Molecular Formula : C29H24F3N7O
Molecular Weight : 543.55
N-[3-(1H-Imidazol-1-yl)-5-(trifluoromethyl)phenyl]-4-methyl-3-[[4-(pyridin-3-yl)pyrimidin-2-yl]amino]benzamide
Catalogue No.:PA 14 85050
Molecular Formula : C27H20F3N7O
Molecular Weight : 515.50
Methyl 4-methyl-3-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)benzoate
Catalogue No.:PA 14 85070
Molecular Formula : C18H16N4O2
Molecular Weight : 320.35
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....
